Karine Sargsyan, formerly director of one of the world’s largest clinical biobanks, was named scientific director of Cedars-Sinai Cancer’s OncoBiobank.
Cedars-Sinai investigators who previously developed an imaging tool that used artificial intelligence to predict pancreatic cancer are now working to adapt that tool specifically for Black patients, who have disproportionately high rates of the disease.
